ABSTRACT
In the realm of cancer therapy and treatment of bacterial infection, photothermal therapy (PTT) stands out as a potential strategy. The challenge, however, is to create photothermal agents that can perform both imaging and PTT, a so-called theranostic agent. Photothermal agents that absorb and emit in the near-infrared region (750-900â nm) have recently received a lot of attention due to the extensive penetration of NIR light in biological tissues. In this study, we combined pyrazole with aza-BODIPY (PY-AZB) to develop a novel photothermal agent. PY-AZB demonstrated great photostability with a photothermal conversion efficiency (PCE) of up to 33 %. Additionally, PY-AZB can permeate cancer cells at a fast accumulation rate in less than 6â hours, according to the confocal images. Furthermore, inâ vitro photothermal therapy results showed that PY-AZB effectively eliminated cancer cells by up to 70 %. Interestingly, PY-AZB exhibited antibacterial activities against both gram-negative bacteria, Escherichia coli 780, and gram-positive bacteria, Staphylococcus aureus 1466. The results exhibit a satisfactory bactericidal effect against bacteria, with a killing efficiency of up to 100 % upon laser irradiation. As a result, PY-AZB may provide a viable option for photothermal treatment.
Subject(s)
Neoplasms , Photochemotherapy , Phototherapy , Boron Compounds/pharmacology , Boron Compounds/therapeutic use , Escherichia coli , Bacteria , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Neoplasms/drug therapyABSTRACT
Photodynamic therapy (PDT) and cannabidiol (CBD) have been explored for their potential in synergistic cancer treatment. In this study, we employed CBD oil as a lipid phase, encapsulated within AZB-I@Lec-T to create lipid-based nanoparticles. Here, CBD oil does two tasks: it acts as a pyroptosis agent to destroy liver cancer cells and as a lipid phase to dissolve the photosensitizer. It was expected that this system would offer synergistic therapy between CBD and PDT better than a single use of each treatment. With a series of in vitro experiments, the nanoparticles exhibited induced apoptosis in 68% of HepG2 cells treated with AZB-I@Lec-T@CBD and near-infrared (NIR)-light irradiation, reducing expression levels of antioxidant defense system genes. Furthermore, both components worked well in a submicromolar range when combined in our formulation. These results highlight the potential for amplifying primary cellular damage with the combination of PDT and CBD encapsulation, providing a promising therapeutic approach for liver cancer treatment guidelines.
Subject(s)
Biocompatible Materials , Boron Compounds , Cannabidiol , Drug Screening Assays, Antitumor , Liver Neoplasms , Materials Testing , Particle Size , Photochemotherapy , Photosensitizing Agents , Humans , Cannabidiol/chemistry , Cannabidiol/pharmacology , Hep G2 Cells , Liver Neoplasms/drug therapy , Liver Neoplasms/pathology , Photosensitizing Agents/chemistry , Photosensitizing Agents/pharmacology , Biocompatible Materials/chemistry , Biocompatible Materials/pharmacology , Boron Compounds/chemistry , Boron Compounds/pharmacology , Apoptosis/drug effects , Cell Survival/drug effects , Antineoplastic Agents/pharmacology , Antineoplastic Agents/chemistry , Cell Proliferation/drug effects , Nanoparticles/chemistryABSTRACT
We designed and optimized a glucose biosensor system based on a screen-printed electrode modified with the NAD-GDH enzyme. To enhance the electroactive surface area and improve the electron transfer efficiency, we introduced graphene oxide (GO) and ferrocene-modified linear poly(ethylenimine) (LPEI-Fc) onto the biosensor surface. This strategic modification exploits the electrostatic interaction between graphene oxide, which possesses a negative charge, and LPEI-Fc, which is positively charged. This interaction results in increased catalytic current during glucose oxidation and helps improve the overall glucose detection sensitivity by amperometry. We integrated the developed glucose sensor into a flow injection (FI) system. This integration facilitates a swift and reproducible detection of glucose, and it also mitigates the risk of contamination during the analyses. The incorporation of an FI system improves the efficiency of the biosensor, ensuring precise and reliable results in a short time. The proposed sensor was operated at a constant applied potential of 0.35 V. After optimizing the system, a linear calibration curve was obtained for the concentration range of 1.0-40 mM (R2 = 0.986). The FI system was successfully applied to determine the glucose content of a commercial sports drink.
Subject(s)
Biosensing Techniques , Ferrous Compounds , Glucose , Graphite , Metallocenes , Polyethyleneimine , Graphite/chemistry , Metallocenes/chemistry , Ferrous Compounds/chemistry , Polyethyleneimine/chemistry , Glucose/analysis , Electrodes , Oxidation-ReductionABSTRACT
Typically, nanomedicine was prepared using a nanocarrier to load cargo for specific purposes. In this work, a carrier-free nanosystem for imaging and photodynamic (PDT)/chemo combination therapy was developed using simple self-assembly of a dye and a chemotherapeutic agent. The resulting nanoparticles (I2-IR783/MTX@NPs) exhibited a spherical morphology with a size of 240.6 ± 2.5 nm. I2-IR783/MTX@NPs had substantial internalization in 4T1 murine breast cancer cells and showed a synergistic anticancer effect after NIR light irradiation. Additionally, the 3D tumor model exhibits the same phototoxicity of nanoparticles as a 2D cell culture. The PDT efficiency of the nanosystem in the physiological environment was confirmed by the detection of intracellular reactive oxygen species as well as the live/dead viability/cytotoxicity assay following NIR light exposure. In addition, optical coherence tomography (OCT) was used as an alternative tool to monitor the response after treatment. Therefore, I2-IR783/MTX@NPs show great potential use in theranostic application for breast cancer PDT-chemotherapy.
Subject(s)
Breast Neoplasms , Nanoparticles , Photochemotherapy , Humans , Animals , Mice , Female , Breast Neoplasms/diagnostic imaging , Breast Neoplasms/drug therapy , Methotrexate , Photochemotherapy/methods , Combined Modality Therapy , Nanoparticles/therapeutic useABSTRACT
In this study, we developed functional nanomaterials via a phenolic-enabled nanotechnology strategy for hypoxia detection employing quercetin (QCT), an abundant flavonoid, as a polyphenolic system. The nano form of QCT was stabilized by coating it with polyethylene glycol (PEG) before loading it with a flavylium dye (Flav) as a pH indicator. The nanosystem, Flav@QCT-PEG, collapsed when it was in an acidic environment, i.e., pH 5, leading to the release of Flav, which activated the fluorescent signal. Therefore, Flav@QCT-PEG was applied to detect hypoxic tumors, known to be acidic, and responded to hypoxic environments in a dose- and time-dependent manner.
Subject(s)
Hypoxia , Nanoparticles , Neoplasms , Quercetin , Quercetin/chemistry , Neoplasms/diagnosis , Neoplasms/pathology , Hypoxia/diagnosis , Polyethylene Glycols/chemistry , Anthocyanins/chemistry , Nanoparticles/chemistry , Humans , Cell Line, Tumor , Hydrogen-Ion Concentration , FluorescenceABSTRACT
Photothermal therapy is a promising treatment modality in the realm of cancer therapy. Photothermal nanomaterials that absorb and emit in the near-infrared range (750-900 nm) have drawn a lot of attention recently because of the deep penetration of NIR light in biological tissue. Most nanomaterials, however, are produced by encapsulating or altering the surface of a nanoplatform, which has limited loading capacity and long-term storage. Herein, we developed a stable polymer conjugated with aza-BODIPY that self-assembled to form nanoparticles (aza-BODIPY-mPEG) with better hydrophilicity and biocompatibility while retaining the dye's photothermal conversion characteristics. Aza-BODIPY-mPEG with a hydrodynamic size of around 170 nm exhibited great photostability and excellent photothermal therapy in vitro and in ovo. Aza-BODIPY-mPEG exhibits approximately 30% better anti-angiogenesis and antitumor activity against implanted xenograft human HCT116 tumor in the chick embryo compared to parent aza-BODIPY-A, altogether suggesting that aza-BODIPY-mPEG is a promising material for cancer photothermal therapy.
ABSTRACT
A highly sensitive and selective optical membrane for determination of Au3+ was synthesized by immobilization of a rhodamine derivative on agarose hydrogel. The sensing dye was synthesized by solvatochromism of rhodamine B via rhodamine lactone-zwitterion equilibrium. UV-vis spectroscopy, scanning electron microscopy (SEM), thermal gravimetric analysis (TGA) and attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) were employed to confirm that the rhodamine-lactone (RhoL) was incorporated into the agarose hydrogel. The results showed that the sensor was highly selective for recognizing Au3+ over other metal ions in real systems. In addition, DFT calculation results suggested that the membrane sensor formed stable complexes with Au3+ through a large number of cation-dipole and ion-ion interactions. In addition, according to changes in signaling upon adding various Au3+ concentration, the limit of detection of Arg-RhoL for Au3+ is calculated to be 5â µM. This approach may provide an easily measurable and inherently sensitive method for Au3+ ion detection in environmental and biological applications.